Measured Wealth Private Client Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Measured Wealth Private Client Group's LLY Position: Q2 2026 in Review
Measured Wealth Private Client Group increased its Eli Lilly (LLY) stake by 6.1% in Q2 2026, buying an estimated $7.15K and bringing the position to 121 shares worth $145K. The position accounts for 0.04% of the portfolio, ranked #228.
Measured Wealth Private Client Group first reported a position in LLY in Q3 2018 and has held it in 25 quarters since. The position peaked at $917K in Q2 2024. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Measured Wealth Private Client Group held 121 shares of Eli Lilly worth $145K as of Q2 2026.
- Measured Wealth Private Client Group bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
- Eli Lilly made up 0.04% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #228 holding.
- Measured Wealth Private Client Group first reported a position in Eli Lilly in Q3 2018 and has held it in 25 quarters since.
- Measured Wealth Private Client Group's Eli Lilly position peaked at $917K in Q2 2024.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.